Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: a review
Verhoef, J.
Clinical Therapeutics 11 Suppl A: 71-82
1988
ISSN/ISBN: 0149-2918 PMID: 3072089 Document Number: 313413
Document emailed within 1 workday
Related Documents
Ballantyne, F.N. 1985: Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections Clinical Therapeutics 7(4): 487-491Kajikawa, H.; Hosokawa, S.; Kameoka, H.; Nishimoto, N.; Miyoshi, S.; Iwao, N.; Mizutani, S. 1984: Effect of cefaclor in urinary tract infections (2) Japanese Journal of Antibiotics 37(8): 1453-1469
Thaichinda, S.; Kositpantawong, N. 2008: Necrotizing skin and soft-tissue infections associated with septicemia: 7 cases report and review Journal of the Medical Association of Thailand 91(1): 117-123
Bradsher, R.W.; Snow, R.M. 1984: Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen American Journal of Medicine 77(4c): 63-67
Schupbach, C.W.; Olovich, K.G.; Dere, W.H. 1992: Efficacy of cefaclor AF in the treatment of skin and skin-structure infections Clinical Therapeutics 14(3): 470-479
Harding, J.W.; Knudsen, E.T. 1970: General practitioners' forum. Flucloxacillin in the treatment of skin and soft-tissue infections Practitioner 205(230): 801-806
Trilla, A.; Miro, J.M. 1995: Identifying high risk patients for Staphylococcus aureus infections: skin and soft tissue infections Journal of ChemoTherapy 7(Suppl 3): 37-43
Gürlich, R.; Adámková, V.; Ulrych, J.; Brodská, H.; Janík, V.; Lindner, J.; Havel, E. 2016: Skin and soft tissue infections (SSTIs) Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 95(4): 141-146
García Victor, F.; Ferrero Doria, R. 2001: Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension Archivos Espanoles de Urologia 54(4): 313-320
Brodie, N.H.; McGhie, R.L.; O'Hara, H.; O'Hara, J.; Rahman, M.K.; Vallé-Jones, J.C. 1980: A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice Pharmatherapeutica 2(7): 494-498
Elston, D.M. 2004: Epidemiology and prevention of skin and soft tissue infections Cutis 73(5 Suppl): 3-7
Guchev, I.A.; Sidorenko, S.V.; Frantsuzov, V.N. 2003: Efficient antimicrobial chemotherapy for skin and soft tissue infections Antibiotiki i Khimioterapiia 48(10): 25-31
Cainzos Fernández, M. 1998: Skin and soft-tissue infections caused by Pseudomonas aeruginosa Revista Clinica Espanola 198 Suppl. 2: 21-24
Weiss, G.G. 2006: The role of fluoroquinolones in the management of skin, soft tissue, and bone infections Medical Economics 83(19): 34-37
Murakawa, G.J. 2004: Common pathogens and differential diagnosis of skin and soft tissue infections Cutis 73(5 Suppl): 7-10
Raczniak, G.A.; Gaines, J.; Bulkow, L.R.; Kinzer, M.H.; Hennessy, T.W.; Klejka, J.A.; Bruce, M.G. 2018: A survey of knowledge, attitudes, and practices towards skin and soft tissue infections in rural Alaska International Journal of Circumpolar Health 75(1): 30603-30603
Lightner, B.A.; McLoughlin, M.A.; Chew, D.J.; Beardsley, S.M.; Matthews, H.K. 2001: Episioplasty for the treatment of perivulvar dermatitis or recurrent urinary tract infections in dogs with excessive perivulvar skin folds: 31 cases (1983-2000) Journal of the American Veterinary Medical Association 219(11): 1577-1581
Iakovlev, V.P.; Krutikov, M.G.; Blatun, L.A.; Izotova, G.N.; Grishina, I.A. 2000: Clinical and laboratory efficacy of the novel difluoroquinolone Sparflo (sparfloxacin) in therapy of skin and soft tissue infections Antibiotiki i Khimioterapiia 45(12): 37-40
Lundbergh, P. 2001: Clinical guidelines developed by the STRAMA group in the county of Stockholm: skin and soft tissue infections Lakartidningen 98(39): 4202-4205
Tassler, H. 1993: Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections American Journal of Medicine 94(3a): 159S-165S